Yu X - Search Results

1

Comparable antigen-specific T cell responses in vaccinees with diverse humoral immune responses after the primary and booster BBIBP-CorV vaccination.

Wei D, Chen Y, Yu X, Lai YD, Xu W, Ji P, Yang Z, Chen E, Zhang X, Wang Y. Wei D, et al. Among authors: yu x. Emerg Microbes Infect. 2022 Dec;11(1):2474-2484. doi: 10.1080/22221751.2022.2130101. Emerg Microbes Infect. 2022. PMID: 36166417 Free PMC article.

2

Comparison of Serum Hepatitis B Virus RNA Levels and Quasispecies Evolution Patterns between Entecavir and Pegylated-Interferon Mono-treatment in Chronic Hepatitis B Patients.

Yu XQ, Wang MJ, Yu DM, Chen PZ, Zhu MY, Huang W, Han Y, Gong QM, Zhang XX. Yu XQ, et al. J Clin Microbiol. 2020 Aug 24;58(9):e00075-20. doi: 10.1128/JCM.00075-20. Print 2020 Aug 24. J Clin Microbiol. 2020. PMID: 32554476 Free PMC article.

3

Retrospective detection of SARS-CoV-2 in hospitalized patients with influenza-like illness.

Yu X, Wei D, Chen Y, Zhang D, Zhang X. Yu X, et al. Emerg Microbes Infect. 2020 Dec;9(1):1470-1473. doi: 10.1080/22221751.2020.1785952. Emerg Microbes Infect. 2020. PMID: 32608335 Free PMC article.

4

Epidemiological and clinical characteristics of three family clusters of COVID-19 transmitted by latent patients in China.

Li J, Ding J, Chen L, Hong L, Yu X, Ye E, Sun G, Zhang B, Zhang X, Sun Q. Li J, et al. Among authors: yu x. Epidemiol Infect. 2020 Jul 6;148:e137. doi: 10.1017/S0950268820001491. Epidemiol Infect. 2020. PMID: 32624076 Free PMC article.

5

Research progress in host immune response during hepatitis B virus infection.

Yu XQ, Zhang XX. Yu XQ, et al. Chin Med J (Engl). 2020 Nov 20;133(22):2746-2748. doi: 10.1097/CM9.0000000000001096. Chin Med J (Engl). 2020. PMID: 33009029 Free PMC article. No abstract available.

6

Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.

Liu C, Yu X, Gao C, Zhang L, Zhai H, Hu Y, Liu E, Wang Q, Gao Y, Wei D, Zhang D, Han Y, Zhang X. Liu C, et al. Among authors: yu x. J Med Virol. 2021 Apr;93(4):2227-2233. doi: 10.1002/jmv.26646. Epub 2020 Nov 10. J Med Virol. 2021. PMID: 33135795

7

Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort.

Liu T, Dai J, Yang Z, Yu X, Xu Y, Shi X, Wei D, Tang Z, Xu G, Xu W, Liu Y, Shi C, Ni Q, Yang C, Zhang X, Wang X, Chen E, Qu J. Liu T, et al. Among authors: yu x. Sci Bull (Beijing). 2021 Nov 30;66(22):2312-2319. doi: 10.1016/j.scib.2021.07.033. Epub 2021 Jul 27. Sci Bull (Beijing). 2021. PMID: 34336365 Free PMC article.

8

Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination.

Yu X, Wei D, Xu W, Li Y, Li X, Zhang X, Qu J, Yang Z, Chen E. Yu X, et al. Cell Discov. 2022 Jan 17;8(1):4. doi: 10.1038/s41421-022-00375-5. Cell Discov. 2022. PMID: 35034952 Free PMC article. No abstract available.

9

Neutralizing activity of BBIBP-CorV vaccine-elicited sera against Beta, Delta and other SARS-CoV-2 variants of concern.

Yu X, Wei D, Xu W, Liu C, Guo W, Li X, Tan W, Liu L, Zhang X, Qu J, Yang Z, Chen E. Yu X, et al. Nat Commun. 2022 Apr 4;13(1):1788. doi: 10.1038/s41467-022-29477-0. Nat Commun. 2022. PMID: 35379815 Free PMC article. Clinical Trial.

10

Sequential reinfection with Omicron variants elicits broader neutralizing antibody profiles in booster vaccinees and reduces the duration of viral shedding.

Wei D, Yu X, Li Y, Chen Y, Chen E, Wang Y, Yang Z, Zhang X. Wei D, et al. Among authors: yu x. J Med Virol. 2023 Oct;95(10):e29151. doi: 10.1002/jmv.29151. J Med Virol. 2023. PMID: 37805829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,947 results

Search Page

Filters